Clinical Trial

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Study acronym: AMAZE 1
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.
Trial Details
NCT Number NCT07339423
Lead Sponsor Novo Nordisk A/S
Conditions Obesity
Enrollment 1,150 participants
Start Date 2026-02-24
Primary Completion 2029-06-26 (estimated)
Study Completion 2029-08-21 (estimated)
Updated on ClinicalTrials.gov 2026-07-09